Related Experiment Videos
Thrombomodulin gene mutations associated with myocardial infarction
H Ireland1, G Kunz, K Kyriakoulis
1Department of Haematology, Charing Cross and Westminster Medical School, London, UK. h.ireland@cxwms.ac.uk
Circulation
|July 1, 1997
Summary
Mutations in the thrombomodulin gene promoter may increase the risk of arterial thrombosis, particularly myocardial infarction. Further research is needed to confirm this association.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Molecular Biology
Background:
- Thrombomodulin acts as a thrombin receptor on endothelial cells.
- Activated protein C, via thrombomodulin, inhibits thrombin generation.
- This pathway is crucial for regulating blood coagulation.
Purpose of the Study:
- To investigate the 5' region of the thrombomodulin gene for mutations.
- To determine if these mutations are associated with myocardial infarction risk.
Main Methods:
- Screening of the thrombomodulin gene promoter region using single-stranded conformation polymorphism analysis.
- Analysis of 104 patients diagnosed with myocardial infarction.
- Comparison with age, sex, and race-matched control subjects.
Main Results:
- Five distinct mutations (GG-9/-10AT, G-33A, C-133A) were identified in the thrombomodulin gene promoter.
- Mutations were found in close proximity to transcription control elements.
- No significant difference in mutation frequency was observed compared to controls for a known neutral polymorphism.
Conclusions:
- Promoter region mutations in the thrombomodulin gene may represent a risk factor for arterial thrombosis.
- These genetic variations could impact thrombomodulin's regulatory functions.
- Further studies are warranted to elucidate the clinical significance.